Wegovy before and after 1 month: what the evidence actually shows

The myth: you should see significant weight loss in your first month

A lot of what circulates online about Wegovy results centres on striking before-and-after comparisons. Almost none of those images represent a single month. The STEP 1 trial, published in the New England Journal of Medicine, followed nearly 2,000 adults over 68 weeks and reported an average body-weight reduction of around 15% at the 2.4 mg maintenance dose. That figure comes from more than a year of treatment. At one month, participants were still on 0.25 mg, the first step in a four-rung titration that takes roughly sixteen weeks to reach the full dose.

This is not a flaw in the medicine. The dose ladder exists because ramping up too quickly produces nausea and vomiting that most people find intolerable. Your stomach is learning a new rhythm. Appetite suppression does begin at 0.25 mg for many people, but it is mild compared with what 1.7 mg or 2.4 mg produces. Treating the first month as a preview, not a verdict, is medically accurate.

If you are comparing your week-four experience to someone else's week-fifty photograph, you are measuring against the wrong timeline. Three months in is when most people start to see changes they can photograph.

What does typically happen in the first four weeks

Realistically, a few things tend to shift during the first month that matter even if the scales have not moved far. Appetite often feels different, meals feel filling sooner, and the mental pull toward snacking can ease. These are early signs the medicine is doing its job pharmacologically, even before large weight changes appear on a scale.

Actual weight lost at four weeks varies considerably between individuals. Some people lose two to three kilograms; others lose very little. Starting weight, diet, activity level, other medicines and individual metabolic response all play a role. How long Wegovy takes to work depends on when titration reaches a therapeutic dose, and for most people that is somewhere between week eight and week sixteen.

On the practical side: Wegovy injection pens need to be kept in the fridge, and many people find that building the injection into an existing weekly habit (putting it in the door next to something they open every morning) is the simplest way to stay consistent. Consistency matters more in month one than in any other period, because the titration schedule only works if doses are not missed.

Side effects are also front-loaded. Nausea, loose stools, and reduced appetite can all be more pronounced during the first month, particularly around dose changes. Full side-effect information for Wegovy is worth reading before you start, so you know what to expect and what would be a reason to contact your prescriber.

How the 1-month picture fits into the longer arc

The STEP 1 trial data show a clear trajectory: weight loss accumulates steadily from the point at which people reach their maintenance dose, not from day one. The average reduction at week 20 was notably lower than at week 68, this is consistent and expected. Looking at Wegovy results at two months gives a slightly better picture of early progress, and before-and-after accounts from the two-month mark reflect that the body is by then responding to a higher dose.

None of this means a one-month check-in is pointless. Quite the opposite. Month one tells you whether you are tolerating the medicine, whether the dose-titration plan is working, and whether any side effects need to be discussed with your prescriber. Those are genuinely important things to know. One-month results for semaglutide across its different branded forms follow a similar pattern for the same pharmacological reasons.

For people asking whether to continue after a month without dramatic results: the broader evidence for Wegovy outcomes is reassuring, but only for those who reach and sustain the maintenance dose. Clinical guidelines suggest reviewing continuation if less than 5% of starting body weight has been lost after six months on the maintenance dose, not after one month on the starter dose. That distinction is significant. The NHS guidance on weight management injections covers the review criteria clearly.

What this means if you are thinking about starting

If you are researching before-and-after results to decide whether Wegovy is worth trying, the most useful frame is not the first month but the full treatment timeline. The trial evidence is robust at 68 weeks. Month one is groundwork.

Wegovy is a prescription-only medicine. A prescriber assesses whether it is clinically appropriate based on your BMI, health history and any other medicines you take, not on how motivated you feel or how urgently you want results. Adults with a BMI of 30 or above, or 27 and above with a relevant weight-related condition, may be eligible, though the prescriber's overall assessment is what determines suitability in practice.

If you would like to understand whether you might be eligible, you can check your eligibility through our free consultation. A GPhC-registered prescriber reviews every application the same day, a real clinician reads your answers, not automated software. There are no subscriptions and no hidden fees; everything is reviewed fresh each time.